Neprilysin  Market Report

Europe Neprilysin  Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 19, 2020
  • PAGES：206
  • REPORT CODE：GMM559148
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Neprilysin  market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Neprilysin  Market Segmentations:

    By Player:

    • Pharmaleads SA

    • Novartis AG

    • Bioprojet SCR

    • Theravance Biopharma Inc

    By Type:

    • TD-0714

    • STR-324

    • PL-265

    • LHW-090

    • Others

    By End-User:

    • Acute Heart Failure

    • Cancer Pain

    • Hypertension

    • Alzheimer's Disease

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neprilysin  Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Neprilysin  Market Size and Growth Rate of TD-0714 from 2014 to 2026

    • 1.3.2 Europe Neprilysin  Market Size and Growth Rate of STR-324 from 2014 to 2026

    • 1.3.3 Europe Neprilysin  Market Size and Growth Rate of PL-265 from 2014 to 2026

    • 1.3.4 Europe Neprilysin  Market Size and Growth Rate of LHW-090 from 2014 to 2026

    • 1.3.5 Europe Neprilysin  Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Neprilysin  Market Size and Growth Rate of Acute Heart Failure from 2014 to 2026

    • 1.4.2 Europe Neprilysin  Market Size and Growth Rate of Cancer Pain from 2014 to 2026

    • 1.4.3 Europe Neprilysin  Market Size and Growth Rate of Hypertension from 2014 to 2026

    • 1.4.4 Europe Neprilysin  Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • 1.4.5 Europe Neprilysin  Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Neprilysin  Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neprilysin  by Major Types

      • 3.4.1 Market Size and Growth Rate of TD-0714

      • 3.4.2 Market Size and Growth Rate of STR-324

      • 3.4.3 Market Size and Growth Rate of PL-265

      • 3.4.4 Market Size and Growth Rate of LHW-090

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Neprilysin  Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neprilysin  by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Acute Heart Failure for Construction

      • 4.4.2 Market Size and Growth Rate of Cancer Pain for Construction

      • 4.4.3 Market Size and Growth Rate of Hypertension for Construction

      • 4.4.4 Market Size and Growth Rate of Alzheimer's Disease for Construction

      • 4.4.5 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Neprilysin  Production Analysis by Top Regions

    • 5.2 Europe Neprilysin  Consumption Analysis by Top Regions

    • 5.3 Europe Neprilysin  Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.3 France Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Production, Import, Consumption and Export Analysis

    6 Product Circulation of Neprilysin  Market among Top Countries

    • 6.1 Top 5 Export Countries in Neprilysin  Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Neprilysin  Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Neprilysin  Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Neprilysin  Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Neprilysin  Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Neprilysin  Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Neprilysin  Landscape Analysis

    • 7.1 Germany Neprilysin  Landscape Analysis by Major Types

    • 7.2 Germany Neprilysin  Landscape Analysis by Major End-Users

    8. UK Neprilysin  Landscape Analysis

    • 8.1 UK Neprilysin  Landscape Analysis by Major Types

    • 8.2 UK Neprilysin  Landscape Analysis by Major End-Users

    9. France Neprilysin  Landscape Analysis

    • 9.1 France Neprilysin  Landscape Analysis by Major Types

    • 9.2 France Neprilysin  Landscape Analysis by Major End-Users

    10. Italy Neprilysin  Landscape Analysis

    • 10.1 Italy Neprilysin  Landscape Analysis by Major Types

    • 10.2 Italy Neprilysin  Landscape Analysis by Major End-Users

    11. Spain Neprilysin  Landscape Analysis

    • 11.1 Spain Neprilysin  Landscape Analysis by Major Types

    • 11.2 Spain Neprilysin  Landscape Analysis by Major End-Users

    12. Poland Neprilysin  Landscape Analysis

    • 12.1 Poland Neprilysin  Landscape Analysis by Major Types

    • 12.2 Poland Neprilysin  Landscape Analysis by Major End-Users

    13. Russia Neprilysin  Landscape Analysis

    • 13.1 Russia Neprilysin  Landscape Analysis by Major Types

    • 13.2 Russia Neprilysin  Landscape Analysis by Major End-Users

    14. Switzerland Neprilysin  Landscape Analysis

    • 14.1 Switzerland Neprilysin  Landscape Analysis by Major Types

    • 14.2 Switzerland Neprilysin  Landscape Analysis by Major End-Users

    15. Turkey Neprilysin  Landscape Analysis

    • 15.1 Turkey Neprilysin  Landscape Analysis by Major Types

    • 15.2 Turkey Neprilysin  Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Landscape Analysis by Top Countries

      • 16.3.1 Denmark Neprilysin  Market Volume and Growth Rate

      • 16.3.2 Finland Neprilysin  Market Volume and Growth Rate

      • 16.3.3 Norway Neprilysin  Market Volume and Growth Rate

      • 16.3.4 Sweden Neprilysin  Market Volume and Growth Rate

      • 16.3.6 Iceland Neprilysin  Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Landscape Analysis by Top Countries

      • 17.3.1 Belgium Neprilysin  Market Volume and Growth Rate

      • 17.3.2 Netherlands Neprilysin  Market Volume and Growth Rate

      • 17.3.3 Luxembourg Neprilysin  Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Landscape Analysis by Top Countries

      • 18.3.1 Estonia Neprilysin  Market Volume and Growth Rate

      • 18.3.2 Latvia Neprilysin  Market Volume and Growth Rate

      • 18.3.3 Lithuania Neprilysin  Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Pharmaleads SA

      • 19.1.1 Pharmaleads SA Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Novartis AG

      • 19.2.1 Novartis AG Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Bioprojet SCR

      • 19.3.1 Bioprojet SCR Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Theravance Biopharma Inc

      • 19.4.1 Theravance Biopharma Inc Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    The List of Tables and Figures (Totals 94 Figures and 196 Tables)

    • Figure Product Picture

    • Figure Neprilysin  Market Size and Growth Rate of TD-0714 Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of STR-324 Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of PL-265 Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of LHW-090 Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of Acute Heart Failure from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Cancer Pain from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Hypertension from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure UK Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure France Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Neprilysin  Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Neprilysin  Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Neprilysin 

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neprilysin  by Different Types from 2014 to 2026

    • Table Consumption Share of Neprilysin  by Different Types from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of TD-0714 Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of STR-324 Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of PL-265 Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of LHW-090 Market, 2015 - 2026 (USD Million)

    • Figure Neprilysin  Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Neprilysin  by Different End-Users from 2014 to 2026

    • Table Consumption Share of Neprilysin  by Different End-Users from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Acute Heart Failure from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Cancer Pain from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Hypertension from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • Figure Neprilysin  Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Neprilysin  Production by Major Regions

    • Table Europe Neprilysin  Production Share by Major Regions

    • Figure Europe Neprilysin  Production Share by Major Countries and Regions in 2014

    • Table Europe Neprilysin  Consumption by Major Regions

    • Table Europe Neprilysin  Consumption Share by Major Regions

    • Table Germany Neprilysin  Production, Import, Consumption and Export Analysis

    • Table UK Neprilysin  Production, Import, Consumption and Export Analysis

    • Table France Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Italy Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Spain Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Poland Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Russia Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Switzerland Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Turkey Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Neprilysin  Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Neprilysin  Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Neprilysin  Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Neprilysin  Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Neprilysin  Consumption by Types from 2014 to 2026

    • Table Germany Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Germany Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Germany Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table UK Neprilysin  Consumption by Types from 2014 to 2026

    • Table UK Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table UK Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table UK Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table France Neprilysin  Consumption by Types from 2014 to 2026

    • Table France Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table France Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table France Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Italy Neprilysin  Consumption by Types from 2014 to 2026

    • Table Italy Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Italy Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Italy Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Spain Neprilysin  Consumption by Types from 2014 to 2026

    • Table Spain Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Spain Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Spain Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Poland Neprilysin  Consumption by Types from 2014 to 2026

    • Table Poland Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Poland Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Poland Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Russia Neprilysin  Consumption by Types from 2014 to 2026

    • Table Russia Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Russia Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Russia Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Neprilysin  Consumption by Types from 2014 to 2026

    • Table Switzerland Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Switzerland Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Switzerland Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Neprilysin  Consumption by Types from 2014 to 2026

    • Table Turkey Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Turkey Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Turkey Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neprilysin  Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neprilysin  Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neprilysin  Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Neprilysin  Market Volume and Growth Rate from 2014 to 2026

    • Table Pharmaleads SA Profiles

    • Table Pharmaleads SA Production, Value, Price, Gross Margin 2014-2019

    • Table Pharmaleads SA Product benchmarking

    • Table Pharmaleads SA Strategic initiatives

    • Table Pharmaleads SA SWOT analysis

    • Table Novartis AG Profiles

    • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis AG Product benchmarking

    • Table Novartis AG Strategic initiatives

    • Table Novartis AG SWOT analysis

    • Table Bioprojet SCR Profiles

    • Table Bioprojet SCR Production, Value, Price, Gross Margin 2014-2019

    • Table Bioprojet SCR Product benchmarking

    • Table Bioprojet SCR Strategic initiatives

    • Table Bioprojet SCR SWOT analysis

    • Table Theravance Biopharma Inc Profiles

    • Table Theravance Biopharma Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Theravance Biopharma Inc Product benchmarking

    • Table Theravance Biopharma Inc Strategic initiatives

    • Table Theravance Biopharma Inc SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US